Impact of the revised (2008) EORTC/MSG definitions for invasive fungal disease on the rates of diagnosis of invasive aspergillosis

Medical Mycology

Volumn 50, Issue 5, 2012, Pages 538-542

  Tsitsikas, Dimitris A ^a   Morin, Amelie ^a   Araf, Shamzah ^a   Murtagh, Bernadine ^a   Johnson, Gemma ^c   Vinnicombe, Sarah ^b   Ellis, Stephen ^b   Suaris, Tamara ^b   Wilks, Mark ^c   Doffman, Sarah ^d   Agrawal, Samir G ^a,c  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b BARTS HEALTH NHS TRUST   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d Worthing Hospital   (United Kingdom)

Author keywords

EORTC MSG; Invasive aspergillosis; Leukaemia; Transplantation

Indexed keywords

GALACTOMANNAN;

ARTICLE; ASPERGILLUS FUMIGATUS; CLINICAL ASSESSMENT TOOL; COMPUTER ASSISTED TOMOGRAPHY; DISEASE CLASSIFICATION; EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER; FEMALE; FUNGUS CULTURE; HIGH RISK PATIENT; HUMAN; INVASIVE ASPERGILLOSIS; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SYSTEMIC MYCOSIS;

ASPERGILLOSIS; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; RETROSPECTIVE STUDIES; TERMINOLOGY AS TOPIC;

EID: 84862187279     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693786.2011.630040     Document Type: Article

References (14)

1. Girmenia C, Barosi G, Aversa F, e t al . Prophylaxis and treatment of invasive fungal diseases in allogeneic stem cell transplantation: results of a consensus process by Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Clin Infect Dis 2009; 49 : 1226-1236.
2. Garcia-Vidal C, Upton A, Kirby KA, Marr KA. Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation. Clin Infect Dis 2008; 15 : 1041-1050.
3. Pagano L, Caira M, Picardi M, e t al . Invasive aspergillosis in patients with acute leukemia: update on morbidity and mortality-SEIFEM-C Report. Clin Infect Dis 2007; 1 : 1524-1525 (Pubitemid 46801604)
4. Pagano L, Caira M, Candoni A, e t al . Invasive aspergillosis in patients with acute myeloid leukemia: SEIFEM-2008 registry study. Haematologica 2010; 95 : 644-650.
5. von Eiff M, Roos N, Schulten R, e t al . Pulmonary aspergillosis: early diagnosis improves survival. Respiration 1995; 62 : 341-347.
6. Ostrosky-Zeichner L, Alexander BD, Kett DH, e t al . Multicenter clinical evaluation of the (1-3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 2005; 41 : 654-659. (Pubitemid 41170353)
7. Kawazu M, Kanda Y, Nannya Y, et al . Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1-3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders. J Clin Microbiol 2004; 42 : 2733-2741. (Pubitemid 38747529)
8. Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: A meta-analysis. Clin Infect Dis 2006; 42 : 1417-1427.
9. Leefl ang MM, Debets-Ossenkopp YJ, Visser CE, e t al . Galactomannan detection for invasive aspergillosis in immunocompromized patients. Cochrane Database Syst Rev 2008; 8 : CD007394.
10. Mengoli C, Cruciani M, Barnes RA, e t al . Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis. Lancet Infect Dis 2009; 9 : 89-96.
11. Sink ó J, Csomor J, Nikolova R, et al . Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: An autopsydriven survey. Transpl Infect Dis 2008; 10 : 106-109. (Pubitemid 351393087)
12. Chamilos G, Luna M, Lewis RE, e t al . Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: An autopsy study over a 15-year period (1989-2003). Haematologica 2006; 91 : 986-989. (Pubitemid 44023159)
13. Ascioglu S, Rex JH, de Pauw B, et al . Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer; Mycoses Study Group of the National Institute of Allergy and Infectious Diseases. Defi ning opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus. Clin Infect Dis 2002; 34 : 7-14.
14. De Pauw B, Walsh TJ, Donnelly JP, e t al . European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Revised defi nitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46 : 1813-1821.